January 18, 2013 — nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
January 8, 2013 — The results of a recent study presented yesterday at the American Heart Association Scientific ...
November 15, 2012 — The U.S. Patent and Trademark Office has awarded Biomedical Systems U.S. Patent Number 8301236 for ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
October 8, 2012 — The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments ...
October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to ...
September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
September 11, 2012 — Since the previous consensus document was published in 2007, catheter and surgical ablation of atri ...
September 10, 2012 — Atrial fibrillation (AF) is a common complication of cardiac surgery, occurring in 10 to 40 percent ...
August 30, 2012 — Baseline data from the first cohort of the Global Anticoagulant Registry in the Field (GARFIELD), an ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge ...
July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and ...
Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...